tiprankstipranks
Trending News
More News >
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market

Gland Pharma Ltd. (GLAND) Financial Statements

Compare
1 Followers

Gland Pharma Ltd. Financial Overview

Gland Pharma Ltd.'s market cap is currently ₹304.07B. The company's EPS TTM is ₹16.95; its P/E ratio is 34.99; and it has a dividend yield of 1.07%. Gland Pharma Ltd. is scheduled to report earnings on January 28, 2026, and the estimated EPS forecast is ₹14.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 56.17B₹ 56.65B₹ 36.25B₹ 44.01B₹ 34.63B
Gross Profit₹ 31.54B₹ 31.11B₹ 17.65B₹ 21.51B₹ 18.53B
Operating Income₹ 17.38B₹ 18.23B₹ 11.57B₹ 15.84B₹ 14.19B
EBITDA₹ 12.31B₹ 12.97B₹ 10.31B₹ 15.10B₹ 13.02B
Net Income₹ 6.99B₹ 7.72B₹ 7.81B₹ 12.12B₹ 9.97B
Balance Sheet
Cash & Short-Term Investments₹ 29.52B₹ 19.39B₹ 37.63B₹ 32.43B₹ 30.03B
Total Assets₹ 112.25B₹ 106.61B₹ 87.78B₹ 78.34B₹ 64.96B
Total Debt₹ 3.14B₹ 3.72B₹ 44.53M₹ 47.43M₹ 49.95M
Net Debt₹ -22.42B₹ 150.78M₹ -19.04B₹ -3.11B₹ -4.87B
Total Liabilities₹ 20.74B₹ 19.37B₹ 8.19B₹ 6.76B₹ 5.93B
Stockholders' Equity₹ 91.51B₹ 87.24B₹ 79.59B₹ 71.58B₹ 59.03B
Cash Flow
Free Cash Flow₹ 5.30B₹ 6.07B₹ 1.41B₹ 2.69B₹ 3.76B
Operating Cash Flow₹ 9.15B₹ 9.97B₹ 3.64B₹ 7.91B₹ 6.05B
Investing Cash Flow₹ 17.05B₹ -17.57B₹ 12.08B₹ -10.03B₹ -15.24B
Financing Cash Flow₹ -4.33B₹ -7.99B₹ 149.19M₹ 348.98M₹ 12.38B
Currency in INR

Gland Pharma Ltd. Earnings and Revenue History

Gland Pharma Ltd. Debt to Assets

Gland Pharma Ltd. Cash Flow

Gland Pharma Ltd. Forecast EPS vs Actual EPS